FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of the formula [I] wherein n is 1 or 2, or to its corresponding pharmaceutically acceptable salts. Invention also relates to compounds represented by formulas [II], [IIh] and [III]. Pharmaceutical use of these compounds is also described.
EFFECT: these compounds are an inhibitor of PDHK (PDHK1 and / or PDHK2).
15 cl, 2 dwg, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NITROGEN-CONTAINING HETEROCYCLIC AMIDE AND ITS USE FOR MEDICAL PURPOSES | 2019 |
|
RU2789670C2 |
| METHOD OF PRODUCING A PYRAZOLAMIDE COMPOUND | 2017 |
|
RU2736722C2 |
| HYDROXYPYRIDOXAZEPINES AS Nrf2 ACTIVATORS | 2020 |
|
RU2812931C2 |
| IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
| PYRIDYLOXY DERIVATIVES EFFECTIVE AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA ACTIVATOR/MODULATOR | 2010 |
|
RU2480463C1 |
| CRYSTAL AND SALT FORMS OF PPAR AGONIST COMPOUNDS | 2017 |
|
RU2759724C2 |
| METHODS, COMPOUNDS AND COMPOSITIONS FOR TREATING ANGIOTENSIN-ASSOCIATED DISEASES | 2014 |
|
RU2688163C2 |
| PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR APPLICATION | 2017 |
|
RU2746602C2 |
| BENZENE OR THIOPHEN DERIVATIVE AND USING IT AS VAP-1 INHIBITOR | 2009 |
|
RU2526256C2 |
| DIPEPTIDYL KETOAMIDE META-METHOXYPHENYL DERIVATIVES AND THEIR USE | 2019 |
|
RU2787766C2 |
